Answers are grounded in this paper and cite their sources.
The development of Alzheimer's disease (AD) biomarkers remains an unmet challenge, and new approaches that can improve current AD biomarker strategies are needed. Recent reports suggested that microRNA (miRNA) profiling of biological fluids has emerg
No takes yet. Share an insight, caveat, or question.
Kiko et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: